Additional file 1 of Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

Krieger, Tina; Pearson, Isobel; Bell, Judith; Doherty, Jim; Robbins, Paul

doi:10.6084/m9.figshare.11776020.v1

13000_2020_927_MOESM1_ESM.docx (907.98 kB)

Additional file 1 of Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

journal contribution

posted on 2020-01-31, 04:52 authored by Tina Krieger, Isobel Pearson, Judith Bell, Jim Doherty, Paul Robbins

Additional file 1: Table S1. Summary of Study Characteristics. Table S2. PD-L1: OS and PFS Data in NSCLC. Table S3. PD-L1 and TMB: OS and PFS Data in NSCLC. Table S4. PD-L1: OS and PFS Data in Melanoma

History

Usage metrics

Keywords

Precision medicine Biomarkers Tumor mutational burden Programmed cell death 1 receptor Gene expression profiling

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

History

Usage metrics

Categories

Keywords

Licence

Exports